Skip to main content

MoneyWorks4Me

Earum Pharmaceuticals informs about disclosure

19 Jan 2022 Evaluate
Earum Pharmaceuticals has informed that exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendrakumar G Patel.

The above information is a part of company’s filings submitted to BSE.

Peers